Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why This Connecticut Biotech Could be a $1M Opportunity for Investors January 23, 2018 Oramed Granted Canadian Patent For GLP-1 Analog Capsule May 8, 2017 GRAIL Poaches New CEO From Roche, Genentech December 13, 2017